Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 387

1.

Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.

Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P.

J Infect Dis. 2007 Feb 1;195(3):322-9. Epub 2006 Dec 21.

PMID:
17205469
2.

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.

Priotto G, Kasparian S, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Karunakara U.

Clin Infect Dis. 2007 Dec 1;45(11):1435-42. Epub 2007 Oct 22.

PMID:
17990225
3.

Randomized, controlled trial of treatments for second-stage sleeping sickness.

Woodrow CJ, Abel PM, Krishna S.

J Infect Dis. 2007 Aug 15;196(4):650-1. No abstract available.

PMID:
17624857
4.

High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire.

Pépin J, Milord F, Meurice F, Ethier L, Loko L, Mpia B.

Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):254-6.

PMID:
1412646
5.

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.

Burri C, Nkunku S, Merolle A, Smith T, Blum J, Brun R.

Lancet. 2000 Apr 22;355(9213):1419-25.

PMID:
10791526
6.

Chemotherapy for second-stage Human African trypanosomiasis.

Lutje V, Seixas J, Kennedy A.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD006201. doi: 10.1002/14651858.CD006201.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD006201.

PMID:
20687080
7.

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.

Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Baudin E, Buard V, Kazadi-Kyanza S, Ilunga M, Mutangala W, Pohlig G, Schmid C, Karunakara U, Torreele E, Kande V.

Lancet. 2009 Jul 4;374(9683):56-64. doi: 10.1016/S0140-6736(09)61117-X. Epub 2009 Jun 24.

PMID:
19559476
8.

Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis.

Pépin J, Mpia B.

Trans R Soc Trop Med Hyg. 2006 May;100(5):437-41. Epub 2006 Feb 17.

PMID:
16483622
9.

Chemotherapy for second-stage human African trypanosomiasis.

Lutje V, Seixas J, Kennedy A.

Cochrane Database Syst Rev. 2013 Jun 28;(6):CD006201. doi: 10.1002/14651858.CD006201.pub3. Review.

PMID:
23807762
10.

The phenomenon of treatment failures in Human African Trypanosomiasis.

Brun R, Schumacher R, Schmid C, Kunz C, Burri C.

Trop Med Int Health. 2001 Nov;6(11):906-14.

11.

Advances in sleeping sickness therapy.

Van Nieuwenhove S.

Ann Soc Belg Med Trop. 1992;72 Suppl 1:39-51.

PMID:
1417168
12.
13.
14.
15.

Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.

Chappuis F.

Clin Infect Dis. 2007 Dec 1;45(11):1443-5. Epub 2007 Oct 22. No abstract available.

PMID:
17990226
16.

Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo.

Balasegaram M, Harris S, Checchi F, Ghorashian S, Hamel C, Karunakara U.

Bull World Health Organ. 2006 Oct;84(10):783-91.

17.

Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda.

Politi C, Carrín G, Evans D, Kuzoe FA, Cattand PD.

Health Econ. 1995 Jul-Aug;4(4):273-87.

PMID:
8528430
18.

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).

Schmid C, Richer M, Bilenge CM, Josenando T, Chappuis F, Manthelot CR, Nangouma A, Doua F, Asumu PN, Simarro PP, Burri C.

J Infect Dis. 2005 Jun 1;191(11):1922-31. Epub 2005 May 2.

PMID:
15871127
19.

The treatment of human African trypanosomiasis.

Pépin J, Milord F.

Adv Parasitol. 1994;33:1-47. Review. No abstract available.

PMID:
8122565
20.

[A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].

Eozenou P, Jannin J, Ngampo S, Carme B, Tell GP, Schechter PJ.

Med Trop (Mars). 1989 Apr-Jun;49(2):149-54. French.

PMID:
2507863

Supplemental Content

Support Center